Additionally, NCD Vsig4−/− recipient mice treated with obese mEVs had significantly lower levels of insulin secretion in response to glucose injection and impaired glucose tolerance (Figs. 3b and S3g). This evidence concerns the gene INS and Impaired glucose tolerance.